Arachidonic acid is a polyunsaturated fat woven into nearly every cell membrane in your body, where it sits quietly until something triggers its release. Once freed, it becomes the raw material for dozens of signaling molecules that drive inflammation, regulate blood flow, shape immune responses, and influence brain function. The reputation it carries in nutrition circles tends to be one-dimensional: it’s “the inflammatory omega-6.” The reality is considerably more interesting, because the same molecule that fuels a swollen joint also helps resolve that swelling, relaxes blood vessels, and supports infant brain development.
Where Arachidonic Acid Comes From
Your body gets arachidonic acid two ways: directly from food, or by building it from linoleic acid, an essential omega-6 fat abundant in vegetable oils, nuts, and seeds. The conversion from linoleic acid to arachidonic acid follows a multi-step chain of reactions involving desaturase and elongase enzymes, with a delta-6 desaturase performing the first and rate-limiting step.1Journal of Lipid Research. Metabolism of essential fatty acids by human epidermal enzyme preparations: evidence of chain elongation The liver handles most of this conversion. Research in rats shows the liver’s daily output of arachidonic acid exceeds what the brain alone consumes by roughly 27-fold, which matters because the brain and heart cannot efficiently make arachidonic acid on their own and depend on the liver to supply it.2PubMed Central. Quantifying conversion of linoleic to arachidonic and other n-6 polyunsaturated fatty acids in unanesthetized rats
Dietary sources of preformed arachidonic acid include eggs, poultry, red meat, organ meats, and fatty fish. In a typical Western diet, direct intake from food is substantial enough that the conversion pathway from linoleic acid plays a secondary role. But on plant-heavy diets low in animal products, that enzymatic conversion becomes the primary supply line, which is one reason the efficiency of those desaturase enzymes varies so much between individuals and populations.
How It Gets Released From Cell Membranes
Arachidonic acid doesn’t float freely in your blood in large quantities. Instead, it’s locked into the phospholipid bilayer of cell membranes, essentially stored there until needed. When a cell receives certain signals, such as an injury signal, an immune trigger, or a hormonal cue, an enzyme called phospholipase A2 (PLA2) cuts arachidonic acid loose.3PubMed Central. Arachidonic acid metabolism in health and disease The most studied form of this enzyme, called cPLA2α, responds to a rise in intracellular calcium by moving from the interior of the cell to the membrane surface. Calcium helps the enzyme latch on; then phosphorylation fine-tunes its cutting activity.4Journal of Lipid Research. Biology of group IV phospholipase A2 family This two-step activation, calcium plus phosphorylation, is one reason the release of arachidonic acid is tightly controlled rather than happening continuously.
There are also secreted forms of phospholipase A2 that work differently. One type, group I PLA2, triggers arachidonic acid release not by directly cutting it from membranes but by activating a receptor on the cell surface, which then signals the cell to release the fatty acid through its own internal machinery.5PubMed. Arachidonic acid release from NIH 3T3 cells by group-I phospholipase A2: involvement of a receptor-mediated mechanism This receptor-mediated route takes longer to get going and adds another layer of regulation.
Three Enzymatic Pathways and What They Produce
Once arachidonic acid is freed from the membrane, three major enzyme families compete to process it, and the products of each have very different effects.
The cyclooxygenase (COX) pathway is the most clinically familiar. COX enzymes convert arachidonic acid into prostaglandins and thromboxanes, molecules that promote pain, fever, swelling, and blood clotting.6PubMed Central. Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney There are two main COX enzymes. COX-1 operates continuously in most tissues and maintains baseline functions like protecting the stomach lining and enabling platelets to clump during a cut. COX-2 ramps up during inflammation and injury. In activated platelets, COX-1 makes thromboxane A2, a potent vasoconstrictor and clotting promoter. In blood vessel walls, COX-2 makes prostacyclin, which does the opposite: it relaxes vessels and discourages clots.7Cardiovascular Research. The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis This thromboxane-prostacyclin balance is central to cardiovascular health, and disrupting it is exactly what drugs like aspirin and COX-2 inhibitors do, for better and worse.
The lipoxygenase (LOX) pathway produces leukotrienes, which are powerful drivers of allergic and inflammatory responses. Leukotrienes constrict airways and attract white blood cells to sites of infection or injury. But this same pathway also generates lipoxins, molecules that do the exact opposite: they act as “stop signals” that tell neutrophils to stand down and actively promote the resolution of inflammation.8PubMed. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution Lipoxins form during cell-to-cell interactions, particularly between platelets and white blood cells or between white blood cells and the cells lining mucosal surfaces.9PubMed. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution They represent a genuine anti-inflammatory output of arachidonic acid, which complicates the simple narrative that omega-6 fats are uniformly inflammatory.
The cytochrome P450 (CYP) pathway is the least discussed of the three but no less important. CYP epoxygenases convert arachidonic acid into epoxyeicosatrienoic acids (EETs), which relax blood vessels by activating potassium channels in smooth muscle cells.10Journal of Lipid Research. Epoxyeicosatrienoic acids: properties, functions, and mechanisms of action EETs were originally identified as one of the mysterious “endothelium-derived hyperpolarizing factors” that cause arteries to dilate.11Prostaglandins Leukotrienes and Essential Fatty Acids. Cytochrome P450 metabolites of arachidonic acid: Rapid incorporation and hydration of 14,15-epoxyeicosatrienoic acid in arterial smooth muscle cells CYP hydroxylases also make 20-HETE, which acts on blood vessel smooth muscle and endothelial cells with effects on vascular tone and function.12PubMed Central. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function So through the CYP pathway, arachidonic acid contributes directly to blood pressure regulation and vascular health.
How Common Drugs Intervene in These Pathways
If you’ve ever taken ibuprofen, aspirin, or a prescription corticosteroid, you’ve directly manipulated arachidonic acid metabolism. Nonsteroidal anti-inflammatory drugs (NSAIDs) work by blocking COX enzymes, which cuts off prostaglandin production and reduces pain, fever, and swelling.13PubMed Central. Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level Low-dose aspirin is more selective: it irreversibly disables COX-1 in platelets, suppressing thromboxane A2 and reducing the risk of clot-driven heart attacks and strokes.14Cardiovascular Research. The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis An intriguing side effect of aspirin is that it triggers the production of “aspirin-triggered lipoxins,” which are structural cousins of naturally occurring lipoxins and share their inflammation-resolving properties.15PubMed. Lipoxins and new lipid mediators in the resolution of inflammation This means aspirin doesn’t just block inflammatory products; it actively redirects arachidonic acid metabolism toward resolution.
Corticosteroids take a broader approach. According to one model, glucocorticoids shift arachidonic acid metabolism globally, diverting the supply away from prostaglandin production and toward the synthesis of endocannabinoids like anandamide and 2-AG, which are themselves arachidonic acid derivatives with anti-inflammatory properties.16PubMed Central. Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: a non-genomic anti-inflammatory switch Glucocorticoids also suppress COX-2 synthesis and inhibit phospholipase A2, which is why topical steroids are effective in skin conditions where arachidonic acid metabolites drive inflammation.17PubMed. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis
The Omega-3 Competition
One of the most practically relevant facts about arachidonic acid is that omega-3 fatty acids, particularly EPA, compete with it at every step. EPA and arachidonic acid use the same desaturase enzymes during synthesis, the same phospholipase enzymes for membrane release, and the same COX and LOX enzymes for downstream processing. When EPA is present in higher concentrations, it shouldered arachidonic acid aside. In liver cells, adding EPA significantly decreased arachidonic acid-dependent prostaglandin E2 synthesis and COX-2 expression.18Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids. β-oxidation modulates metabolic competition between eicosapentaenoic acid and arachidonic acid regulating prostaglandin E2 synthesis in rat hepatocytes–Kupffer cells Computational modeling of this competition in immune cells has confirmed that EPA binds to COX with higher affinity than arachidonic acid, effectively inhibiting its metabolism.19PubMed Central. Computational Modeling of Competitive Metabolism Between ω3- and ω6 Polyunsaturated Fatty Acids in Inflammatory Macrophages
This competition is why the ratio of omega-6 to omega-3 in the diet gets so much attention. A diet heavy in omega-6 sources (vegetable oils, processed foods) and light in omega-3 sources (fatty fish, flaxseed) tilts the metabolic balance toward arachidonic acid-derived prostaglandins and leukotrienes, favoring a more inflammatory baseline. Increasing omega-3 intake shifts the balance in the other direction. The products EPA generates through COX and LOX enzymes are generally less inflammatory than their arachidonic acid-derived counterparts, which is one mechanism behind the anti-inflammatory effects attributed to fish oil.
Brain Function and Infant Development
Arachidonic acid is one of the two most abundant long-chain polyunsaturated fats in the brain, alongside DHA (an omega-3). It plays a structural role, helping maintain the fluidity and flexibility of neuron membranes, which matters for how efficiently nerve cells transmit signals. In aging rats, long-term dietary supplementation with arachidonic acid preserved membrane fluidity in hippocampal neurons and maintained a form of synaptic strengthening associated with learning and memory.20PubMed. Arachidonic acid preserves hippocampal neuron membrane fluidity in senescent rats In those experiments, aged rats fed arachidonic acid showed memory task performance and long-term potentiation comparable to young controls.21PubMed. Synaptic plasticity preserved with arachidonic acid diet in aged rats
For infants, the stakes are particularly high. There is strong evidence from both animal and human research that arachidonic acid is critical for infant growth, brain development, and health.22PubMed Central. The Essentiality of Arachidonic Acid in Infant Development Human breast milk naturally contains arachidonic acid, and infant formulas in many countries are now fortified with it alongside DHA. The inclusion reflects recognition that during the rapid brain growth of the first two years of life, a ready supply of preformed arachidonic acid supports neural development in ways that the infant’s own synthesis from linoleic acid may not fully cover.
The Endocannabinoid Connection
Your body’s endocannabinoid system, which regulates pain perception, mood, appetite, and cardiovascular function, runs largely on arachidonic acid derivatives. The two primary endocannabinoids, anandamide and 2-arachidonoylglycerol (2-AG), are built from arachidonic acid.23PubMed Central. Endocannabinoids anandamide and 2-arachidonoylglycerol are substrates for human CYP2J2 epoxygenase These molecules bind to cannabinoid receptors throughout the body and brain, and their effects overlap with but are distinct from those of plant-derived cannabinoids. Endocannabinoids can themselves be further metabolized by the same CYP enzymes that process free arachidonic acid, creating yet another layer of bioactive products. This means that arachidonic acid availability influences not just inflammatory signaling but also endocannabinoid tone, which connects it to pain modulation and stress responses in ways that go well beyond the standard “inflammatory omega-6” framing.
Arachidonic Acid and Exercise Supplements
Arachidonic acid has attracted interest as a sports supplement, based on the logic that since prostaglandins help signal muscle repair after resistance exercise, providing extra arachidonic acid might amplify that signal and accelerate gains. The evidence so far is mixed and modest. In one study, trained men who took arachidonic acid supplements for eight weeks saw a statistically significant increase in lean body mass of about 2.9%, while the placebo group did not.24PubMed Central. Effects of Arachidonic Acid Supplementation on Acute Anabolic Signaling and Chronic Functional Performance and Body Composition Adaptations Another trial found that arachidonic acid supplementation improved anaerobic peak power and lowered the inflammatory marker IL-6 during training, but produced no statistically significant differences in strength, muscle mass, or markers of muscle protein content.25PubMed Central. Effects of arachidonic acid supplementation on training adaptations in resistance-trained males
When researchers looked at the acute molecular response to a single bout of resistance exercise, arachidonic acid supplementation did not increase muscle protein synthesis over a four-hour recovery period compared to placebo. However, 48 hours after exercise, the arachidonic acid group showed increased ribosome biogenesis, a process that builds the cellular machinery for making proteins over the longer term.26PubMed. Effect of dietary arachidonic acid supplementation on acute muscle adaptive responses to resistance exercise in trained men: a randomized controlled trial The researchers concluded that arachidonic acid may influence translational capacity rather than immediate protein synthesis. In practical terms, the supplement might have a small real effect, but it’s far from the dramatic muscle-builder some marketing suggests.
Metabolic Syndrome and Adipose Tissue
A more concerning association exists between arachidonic acid stored in fat tissue and metabolic health. In a study of Costa Rican adults, people with the highest levels of arachidonic acid in their adipose tissue had roughly six times the odds of metabolic syndrome compared to those with the lowest levels, even after adjusting for body mass index and other metabolic risk factors.27PubMed Central. Adipose Tissue Arachidonic Acid and the Metabolic Syndrome in Costa Rican Adults Adipose arachidonic acid was independently associated with abdominal obesity, high triglycerides, elevated fasting glucose, and high blood pressure. A similar pattern has been observed in children, where arachidonic acid content in fat tissue correlates with insulin resistance during the prepubertal period.28PubMed. Arachidonic acid content in adipose tissue is associated with insulin resistance in healthy children
The proposed mechanism involves the conversion of arachidonic acid in fat tissue into prostaglandins and leukotrienes that sustain low-grade inflammation.29PubMed Central. Resolution of adipose tissue inflammation This chronic, smoldering inflammation in fat depots is increasingly understood as a driver of insulin resistance and related metabolic problems. Whether reducing dietary arachidonic acid would reverse these associations is less clear; the fat-tissue levels reflect long-term dietary patterns and enzymatic conversion rates, not just yesterday’s lunch.
Skin Inflammation
Arachidonic acid metabolism plays a prominent role in inflammatory skin conditions. In psoriasis, the arachidonic acid metabolic pathway is significantly upregulated in affected skin, contributing to the cycle of immune activation and rapid skin cell turnover that characterizes the disease.30PubMed Central. Integrative Analysis of Arachidonic Acid Metabolism in the Pathogenesis and Immune Dysregulation of Psoriasis In both psoriasis and atopic dermatitis, lesional skin contains elevated levels of leukotriene B4, a potent inflammatory product of the lipoxygenase pathway, while healthy skin and uninvolved skin from the same patients have very low or undetectable levels.31PubMed. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis Eicosanoids derived from arachidonic acid also participate in the skin’s response to ultraviolet radiation and play roles in maintaining the skin barrier under normal conditions.32PubMed. Eicosanoids in skin inflammation
Cancer and Immune Regulation
The arachidonic acid pathway has increasingly been studied in the context of cancer immunology. Eicosanoids derived from arachidonic acid can modulate interactions between cancer cells and immune cells within a tumor’s microenvironment, with some metabolites promoting tumor progression and others supporting the immune response against it.33PubMed Central. Immunoregulatory mechanisms of the arachidonic acid pathway in cancer The dual nature of these metabolites, some suppressing and others enhancing anti-tumor immunity, has made the pathway a target for strategies aimed at improving the effectiveness of cancer immunotherapy. This research is still in relatively early stages, but it reinforces the theme that arachidonic acid’s role in the body is context-dependent rather than uniformly harmful.
An Evolutionary Perspective on Fatty Acid Conversion
Genetic variants in the FADS1 gene, which encodes one of the key desaturase enzymes responsible for converting shorter-chain omega-6 fats into arachidonic acid, show strong signatures of natural selection in European populations. Researchers have linked this selection to the shift from hunter-gatherer diets (richer in preformed long-chain fats from animal and fish sources) to agricultural diets (heavier in plant-derived shorter-chain fats). Alleles that increase the efficiency of converting plant-sourced fatty acids into arachidonic acid and its omega-3 counterpart would have been advantageous on grain-heavy diets.34Molecular Biology and Evolution. Selection in Europeans on Fatty Acid Desaturases Associated with Dietary Changes One analysis estimated a selection coefficient of about 0.6% in populations with Steppe ancestry, while finding no significant evidence of selection in hunter-gatherer or Early Farmer populations.35Molecular Biology and Evolution. FADS1 and the Timing of Human Adaptation to Agriculture
This evolutionary imprint means that different populations today carry different baseline capacities for producing arachidonic acid from dietary linoleic acid. People of African descent tend to carry FADS1 variants associated with higher conversion efficiency, while some East Asian and European populations carry lower-activity variants at higher frequencies. These genetic differences could contribute to population-level variation in inflammatory disease risk and in the response to dietary recommendations around omega-6 and omega-3 intake, though this area of research is still developing.
Gut Defense Against Bacterial Pathogens
One of the more unexpected roles of arachidonic acid involves direct antimicrobial effects. In the gut, arachidonic acid can inhibit the virulence of enterohemorrhagic E. coli (EHEC), a dangerous foodborne pathogen. The bacterium has a fatty acid sensing system that recognizes arachidonic acid, and when this system is activated, it represses the genes the pathogen needs to attach to intestinal cells and cause disease.36PubMed Central. The Canonical Long-Chain Fatty Acid Sensing Machinery Processes Arachidonic Acid To Inhibit Virulence in Enterohemorrhagic Escherichia coli Arachidonic acid, once processed by the bacterium’s own enzyme, binds to a transcriptional regulator and decreases its ability to activate virulence genes. The bacterium, in a sense, uses the host’s own fatty acid as a cue that it’s inside a host and should dial down its attack machinery. This finding adds yet another dimension to what arachidonic acid does in the body and suggests that its presence in gut membranes may serve a defensive role alongside its better-known signaling functions.
Why Measuring Arachidonic Acid Metabolites Is Still Difficult
For all the biological importance of the molecules arachidonic acid generates, measuring them reliably remains a challenge for researchers. The products, collectively called oxylipins, exist at very low concentrations in tissues and blood, and many of them are structural near-twins that are hard to tell apart analytically. Current methods rely on sensitive mass spectrometry instruments, but a lack of standardized procedures for collecting and preparing samples, along with the tendency of these molecules to degrade during handling, continues to create problems.37Analytical and Bioanalytical Chemistry. Targeted metabolomics of the arachidonic acid cascade: current state and challenges of LC-MS analysis of oxylipins The limited availability of pure reference standards for many of these compounds makes quantification even harder. This analytical difficulty partly explains why, despite decades of research, precise connections between dietary arachidonic acid intake, tissue levels, and disease outcomes are still debated. The biology is real and well established; the ability to track it precisely in living people lags behind.